Metabolic Associated Fatty Liver Disease Clinical Trials

7 recruitingLast updated: June 18, 2026

There are 7 actively recruiting metabolic associated fatty liver disease clinical trials across 3 countries. Studies span Not Applicable, Early Phase 1. Top locations include Shanghai, Shanghai Municipality, China, Bellaire, Texas, United States, Columbus, Ohio, United States. Updated daily from ClinicalTrials.gov.


Metabolic Associated Fatty Liver Disease Trials at a Glance

7 actively recruiting trials for metabolic associated fatty liver disease are listed on ClinicalTrialsFinder across 6 cities in 3 countries. The largest study group is Not Applicable with 2 trials, with the heaviest enrollment activity in Shanghai, Bellaire, and Columbus. Lead sponsors running metabolic associated fatty liver disease studies include Nanfang Hospital, Southern Medical University, Shanghai Changzheng Hospital, and Foundation for the National Institutes of Health.

Browse metabolic associated fatty liver disease trials by phase

About Metabolic Associated Fatty Liver Disease Clinical Trials

Looking for clinical trials for Metabolic Associated Fatty Liver Disease? There are currently 7 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Metabolic Associated Fatty Liver Disease trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Metabolic Associated Fatty Liver Disease clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 17 of 7 trials

Recruiting
Not Applicable

Glucagon Resistance in Patients With MASLD and T2DM

Type 2 Diabetes (T2DM)Metabolic Associated Fatty Liver Disease
University of Aarhus24 enrolled1 locationNCT07246421
Recruiting
Early Phase 1

Efficacy and Safety of Rifaximin in Treating MAFLD

Metabolic Associated Fatty Liver Disease
Shanghai Changzheng Hospital40 enrolled1 locationNCT07185932
Recruiting

To Explore the Value of New MR Technology in Non-invasive Quantitative Assessment of Systemic Metabolism, Disease Status and Prognosis in Patients With Metabolic-Associated Fatty Liver Disease

Metabolic Associated Fatty Liver DiseaseNonalcoholic Fatty Liver Disease
Tongji Hospital500 enrolled1 locationNCT07149571
Recruiting

Evaluation of Non-Invasive Tests for Metabolic Liver Disease

Cirrhosis, LiverLiver FibrosisLiver Steatoses+5 more
Foundation for the National Institutes of Health400 enrolled4 locationsNCT07122700
Recruiting
Not Applicable

Effect of Low Valine Diet on Body Weight and Metabolic Parameters

Metabolic Associated Fatty Liver DiseaseMetabolic DiseasesOverweight/Obesity
Shanghai Zhongshan Hospital48 enrolled1 locationNCT06883578
Recruiting

Prevalence of MAFLD in Patients With Type 2 Diabetes in Jiangsu Province of China

Metabolic Associated Fatty Liver DiseaseType 2 Diabetes Mellitus in Remission
Wuxi Hisky Medical Technology Co Ltd2,900 enrolled1 locationNCT05597709
Recruiting

A Prospective Cohort Study of Metabolic Associated Fatty Liver Disease in China

Metabolic Associated Fatty Liver Disease
Nanfang Hospital, Southern Medical University3,000 enrolled1 locationNCT04573283